Driven largely by opioid litigation against the pharmaceutical industry, class action settlements rose to unprecedented levels in 2022, a new report published by the law firm Duane Morris found.
Class actions and government enforcement lawsuits against opioid manufactures, retailers and distributors rang up more than $50 billion in settlements last year, according to the Duane Morris Class Action Review, which draws conclusions from the hundreds of rulings in the last year.